Assignee
VANDA PHARMACEUTICALS INC
US·95 granted patents·95 pending applications·414 citations·filing 2006–2025
Top patents by PatentIndex Score
190 records- 0198US11324735B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·7 cites·13 claims
- 0298US11285129B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Mar 29, 2022·8 cites·3 claims
- 0398US10980770B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2020·Granted Apr 20, 2021·7 cites·12 claims
- 0498US8785492B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jul 22, 2014·41 cites·5 claims
- 0597US12201604B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·1 cites·9 claims
- 0697US11667718B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·3 cites·10 claims
- 0797US10829465B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2020·Granted Nov 10, 2020·10 cites·20 claims
- 0897US10610510B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·9 cites·13 claims
- 0997US9060995B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2014·Granted Jun 23, 2015·22 cites·1 claims
- 1096US12447141B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2024·Granted Oct 21, 2025·1 cites·25 claims
- 1196US10653665B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Granted May 19, 2020·8 cites·20 claims
- 1296US10463655B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2016·Granted Nov 5, 2019·8 cites·7 claims
- 1396US10149829B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Dec 11, 2018·13 cites·14 claims
- 1496US9549913B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jan 24, 2017·18 cites·14 claims
- 1596US9539234B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2015·Granted Jan 10, 2017·15 cites·5 claims
- 1695US11759446B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2021·Granted Sep 19, 2023·2 cites·14 claims
- 1795US11266622B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2020·Granted Mar 8, 2022·3 cites·7 claims
- 1895US10611744B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·10 cites·9 claims
- 1995US9730910B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2014·Granted Aug 15, 2017·15 cites·5 claims
- 2094US11918556B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·3 claims
- 2194US11850229B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Dec 26, 2023·1 cites·3 claims
- 2294US11826339B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Nov 28, 2023·1 cites·4 claims
- 2394US11141400B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2020·Granted Oct 12, 2021·3 cites·10 claims
- 2494US11078289B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 3, 2021·5 cites·9 claims
- 2594US10272076B2Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2017·Granted Apr 30, 2019·9 cites·20 claims
- 2694US10071977B2Highly purifid pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2015·Granted Sep 11, 2018·14 cites·24 claims
- 2794US7754902B2Ruthenium(II) catalysts for use in stereoselective cyclopropanationsVANDA PHARMACEUTICALS INC·Filed 2006·Granted Jul 13, 2010·37 cites·11 claims
- 2893US11918557B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·10 claims
- 2993US11760740B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2023·Granted Sep 19, 2023·1 cites·40 claims
- 3093US11737993B2Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 29, 2023·3 cites·13 claims
- 3193US10449176B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·5 cites·9 claims
- 3293US10179119B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2015·Granted Jan 15, 2019·10 cites·10 claims
- 3393US9138432B2Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·12 cites·1 claims
- 3492US10987346B2Iloperidone for the treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·4 cites·13 claims
- 3592US10610511B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Apr 7, 2020·8 cites·19 claims
- 3692US9855241B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·5 cites·9 claims
- 3791US11833130B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·1 cites·10 claims
- 3891US11566011B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·1 cites·5 claims
- 3991US10772880B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2019·Granted Sep 15, 2020·6 cites·13 claims
- 4091US10376487B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2014·Granted Aug 13, 2019·11 cites·20 claims
- 4191US10265282B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 23, 2019·6 cites·10 claims
- 4290US11723903B2Treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2021·Granted Aug 15, 2023·1 cites·11 claims
- 4390US11633377B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Apr 25, 2023·1 cites·11 claims
- 4490US11607408B2Method of treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2020·Granted Mar 21, 2023·2 cites·23 claims
- 4590US10945988B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·3 cites·13 claims
- 4690US2024342120A1Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4790US2026007633A1Liquid Tasimelteon Formulations and Methods of Use ThereofVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4889US12427132B2Method of improving sleepVANDA PHARMACEUTICALS INC·Filed 2022·Granted Sep 30, 2025·1 cites·10 claims
- 4989US10821099B2Use of tradipitant in motion sicknessVANDA PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·5 cites·20 claims
- 5089US9458507B1Antipsychotic treatment based on SNP genotypeVANDA PHARMACEUTICALS INC·Filed 2016·Granted Oct 4, 2016·7 cites·12 claims
Showing the top 50 of 190 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when VANDA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →